Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
暂无分享,去创建一个
H. Levin | C. Reddy | E. Klein | C. Zippe | P. Kupelian | R. Dreicer | Manjula K. Gupta | W. Heston | J. Brainard | Y. Grasso | John Thomas | M. Gupta
[1] P. Kantoff,et al. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] H. Levin,et al. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. , 2000, Urology.
[3] N. Brousse,et al. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence. , 2000, The Journal of urology.
[4] G. Murphy,et al. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction. , 2000, Seminars in surgical oncology.
[5] H. Levin,et al. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] D. Chopin,et al. Blood‐based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow‐up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy , 1999, International journal of cancer.
[7] J. Moul,et al. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer. , 1999, Urology.
[8] R. Figlin,et al. Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging: A Clinicopathological Molecular Analysis of 121 Patients , 1998 .
[9] W. Ellis,et al. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer. , 1998, Journal of Urology.
[10] Manjula.,et al. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. , 1998, Cancer Research.
[11] J. Chmiel,et al. Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. , 1997, The Journal of urology.
[12] F. V. Lente,et al. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] M. Rubin,et al. The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy. , 1996, The Urologic clinics of North America.
[14] M. Benson,et al. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. , 1996, British journal of urology.
[15] B. Lacour,et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. , 1995, Clinical chemistry.
[16] M. Benson,et al. Molecular Stating of Prostate Cancer. II. A Comparison of the Application of an Enhanced Reverse Transcriptase Polymerase Chain Reaction Assay for Prostate Specific Antigen Versus Prostate Specific Membrane Antigen , 1995 .
[17] A. Deblasio,et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.
[18] S. Schwartz,et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. , 1994, Cancer research.
[19] M. Benson,et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.